Cue Biopharma Inc buy Piper Sandler
Start price
06.11.23
/
50%
€2.38
Target price
06.11.24
€7.45
Performance (%)
-44.21%
Price
24.04.24
€1.33
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler for Cue Biopharma Inc is performing very badly with a performance of -44.21%. This prediction currently runs until 06.11.24. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cue Biopharma Inc | -24.000% | -24.000% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Piper_Sandler for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target raised by analysts at Piper Sandler from $7.00 to $8.00. They now have an "overweight" rating on the stock.
Ratings data for CUE provided by MarketBeat